Role of Osteocyte-derived Insulin-Like Growth Factor I in Developmental Growth, Modeling, Remodeling, and Regeneration of the Bone

키워드

참고문헌 (95)

1. Kimmel DB., "A paradigm for skeletal strength homeostasis", J Bone Miner Res., 8(Suppl 2), pp.S515~522 (1993)
2. Kobayashi S., "Trabecular minimodeling in human iliac bone", Bone., 32, pp.163~169 (2003)
3. Manolagas SC., "Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis", Endocr Rev., 21, pp.115~137 (2000)
4. Atkins GJ., "Osteocyte regulation of bone mineral: a little give and take", Osteoporos Int, 23, pp.2067~2079 (2012)
5. Polig E., "A model of osteon closure in cortical bone", Calcif Tissue Int., 47, pp.261~269 (1990)
6. Franz-Odendaal TA., "Buried alive: how osteoblasts become osteocytes", Dev Dyn., 235, pp.176~190 (2006)
7. Bonewald LF., "The amazing osteocyte", J Bone Miner Res., 26, pp.229~238 (2011)
8. Winkler DG., "Osteocyte control of bone formation via sclerostin, a novel BMP antagonist", EMBO J., 22, pp.6267~6276 (2003)
9. Nakashima T., "Evidence for osteocyte regulation of bone homeostasis through RANKL expression", Nat Med., 17, pp.1231~1234 (2011)
10. Xiong J., "Matrix-embedded cells control osteoclast formation", Nat Med., 17, pp.1235~1241 (2011)
11. Bonewald LF., "Osteocytes as dynamic multifunctional cells", Ann N Y Acad Sci., 1116, pp.281~290 (2007)
12. Feng JQ., "Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia", Bone., 54, pp.213~221 (2013)
13. Quarles LD., "Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism", Nat Rev Endocrinol., 8, pp.276~286 (2012)
14. Mohan S., "Bone growth factors", Clin Orthop Relat Res., 30, pp.48~ (1991)
15. McCarthy TL., "Insulin-like growth factor (IGF) and bone", Connect Tissue Res., 20, pp.277~282 (1989)
16. Grinspoon SK., "Effects of rhIGF-I administration on bone turnover during short-term fasting", J Clin Invest., 96, pp.900~906 (1995)
17. Behringer RR., "Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice", Endocrinology., 127, pp.1033~1040 (1990)
18. Mohan S., "Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms", Endocrinology., 144, pp.929~936 (2003)
19. Wang Y., "Role of IGF-I signaling in regulating osteoclastogenesis", J Bone Miner Res., 21, pp.1350~1358 (2006)
20. Lean JM., "Osteocytic expression of mRNA for c-fos and IGF-I: an immediate early gene response to an osteogenic stimulus", Am J Physiol., 270, pp.E937~945 (1996)
21. Sjögren K., "Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice", Proc Natl Acad Sci U S A., 96, pp.7088~7092 (1999)
22. Govoni KE., "Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion", Endocrinology., 148, pp.5706~5715 (2007)
23. Govoni KE., "Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice", Physiol Genomics., 30, pp.354~362 (2007)
24. Turner CH., "Bone strength: current concepts", Ann N Y Acad Sci., 1068, pp.429~446 (2006)
25. Hara M., "Calcium influx through a possible coupling of cation channels impacts skeletal muscle satellite cell activation in response to mechanical stretch", Am J Physiol Cell Physiol., 302, pp.C1741~1750 (2012)
26. Ishihara Y., "Ex vivo real-time observation of Ca(2+) signaling in living bone in response to shear stress applied on the bone surface", Bone., 53, pp.204~215 (2013)
27. Soria B., "Single mechanosensitive and Ca(2)(+)-sensitive channel currents recorded from mouse and human embryonic stem cells", J Membr Biol., 246, pp.215~230 (2013)
28. Gaston J., "The response of vocal fold fibroblasts and mesenchymal stromal cells to vibration", PLoS One., 7, pp.e30965~ (2012)
29. Kamioka H., "Primary cultures of chick osteocytes retain functional gap junctions between osteocytes and between osteocytes and osteoblasts", Microsc Microanal., 13, pp.108~117 (2007)
30. Kamioka H., "A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy", Bone., 28, pp.145~149 (2001)
31. Tatsumi S., "Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction", Cell Metab., 5, pp.464~475 (2007)
32. Kapur S., "Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways", Bone., 32, pp.241~251 (2003)
33. Lau KH., "Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL", 6J osteoblasts as opposed to C3H, J Biol Chem., pp.2006, 281[DOI]
34. Pavalko FM., "Fluid shear-induced mechanical signaling in MC3T3-E1 osteoblasts requires cytoskeleton-integrin interactions", Am J Physiol., 275, pp.C1591~1601 (1998)
35. Temiyasathit S., "Mechanosensing by the primary cilium: deletion of Kif3A reduces bone formation due to loading", PLoS One., 7, pp.e33368~ (2012)
36. Xiao Z., "Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice", FASEB J., 25, pp.2418~2432 (2011)
37. Zhou H., "Osteoblast", osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species, 2011, pp.49, 404~411
38. Grimston SK., "Connexin43 deficiency reduces the sensitivity of cortical bone to the effects of muscle paralysis", J Bone Miner Res., 26, pp.2151~2160 (2011)
39. Kawata A., "Mechanotransduction in stretched osteocytes--temporal expression of immediate early and other genes", Biochem Biophys Res Commun., 246, pp.404~408 (1998)
40. Reijnders CM., "Effect of mechanical loading on insulin-like growth factor-I gene expression in rat tibia", J Endocrinol., 192, pp.131~140 (2007)
41. Gross TS., "Noninvasive loading of the murine tibia: an in vivo model for the study of mechanotransduction", J Bone Miner Res, 17, pp.493~501 (2002)
42. Sakata T., "Skeletal unloading induces resistance to insulin-like growth factor I on bone formation", Bone., 32, pp.669~680 (2003)
43. Sakata T., "Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways", J Bone Miner Res., 19, pp.436~446 (2004)
44. Kesavan C., "Conditional disruption of IGF-I gene in type 1alpha collagen-expressing cells shows an essential role of IGF-I in skeletal anabolic response to loading", Am J Physiol Endocrinol Metab., 301, pp.E1191~1197 (2011)
45. Lau KH., "Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity", Am J Physiol Endocrinol Metab., 305, pp.E271~281 (2013)
46. Sheng MH., "Disruption of the insulin-like growth factor-1 gene in osteocytes impairs developmental bone growth in mice", Bone., 52, pp.133~144 (2013)
47. Olsen BR., "Bone development", Annu Rev Cell Dev Biol., 16, pp.191~220 (2000)
48. Ahlborg HG., "Bone loss and bone size after menopause", N Engl J Med., 349, pp.327~334 (2003)
49. Orwoll ES., "Toward an expanded understanding of the role of the periosteum in skeletal health", J Bone Miner Res., 18, pp.949~954 (2003)
50. Libanati C., "Studies on the potential mediators of skeletal changes occurring during puberty in girls", J Clin Endocrinol Metab., 84, pp.2807~2814 (1999)
51. Heaney RP., "Peak bone mass", Osteoporos Int., 11, pp.985~1009 (2000)
52. van der Eerden BC., "Systemic and local regulation of the growth plate", Endocr Rev., 24, pp.782~801 (2003)
53. Mackie EJ., "The skeleton: a multi-functional complex organ: the growth plate chondrocyte and endochondral ossification", J Endocrinol., 211, pp.109~121 (2011)
54. Ohlsson C., "The role of liver-derived insulin-like growth factor-I", Endocr Rev., 30, pp.494~535 (2009)
55. Olson LE., "The role of GH", IGF-I-mediated mechanisms in sex differences in cortical bone size in mice, 2011, pp.88, 1~8
56. Mohan S., "Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 levels in aging and age-associated diseases", Endocrine., 7, pp.87~91 (1997)
57. Yamada PM., "Perspectives in mammalian IGFBP-3 biology: local vs. systemic action", Am J Physiol Cell Physiol., 296, pp.C954~976 (2009)
58. Zhang P., "Elbow loading promotes longitudinal bone growth of the ulna and the humerus", J Bone Miner Metab., 30, pp.31~39 (2012)
59. Li X., "Sclerostin binds to LRP5", 6 and antagonizes canonical Wnt signaling, 2005, pp.280, 19883~19887
60. Wijenayaka AR., "Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway", PLoS One., 6, pp.e25900~ (2011)
61. Poole KE., "Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation", FASEB J., 19, pp.1842~1844 (2005)
62. Collins JN., "Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes", Endocrinology., 154, pp.1400~1413 (2013)
63. Bélanger LF., "Osteocytic osteolysis", Calcif Tissue Res., 4, pp.1~12 (1969)
64. Parfitt AM., "The cellular basis of bone turnover and bone loss : a rebuttal of the osteocytic resorption--bone flow theory", Clin Orthop Relat Res., 1977, pp.236~247 (1977)
65. Boyde A., "Evidence against osteocytic osteolysis", Metab Bone Dis Relat Res., 2S, pp.239~255 (1980)
66. Qing H., "Demonstration of osteocytic perilacunar", canalicular remodeling in mice during lactation, 2012, pp.27, 1018~1029
67. Tazawa K., "Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered", J Bone Miner Metab., 22, pp.524~529 (2004)
68. Qing H., "Osteocyte remodeling of the perilacunar and pericanalicular matrix", Int J Oral Sci., 1, pp.59~65 (2009)
69. Kogawa M., "Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2", J Bone Miner Res., 28, pp.2436~2448 (2013)
70. Bikle DD., "Insulin like growth factor-I: a critical mediator of the skeletal response to parathyroid hormone", Curr Mol Pharmacol., 5, pp.135~142 (2012)
71. Rhee Y., "PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling", J Bone Miner Res., 26, pp.1035~1046 (2011)
72. Saini V., "Parathyroid hormone (PTH)", PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH, 2013, pp.288, 20122~20134
73. Sheng MH, "Dichotomy in osteocyte regulation of anabolic action of mechanical loading challenge and that of bone repletion after a low dietary calcium challenge", ASBMR 2013 Annual Meeting (2013), American Society for Bone and Mineral Research
74. Li C, "Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene", Bone., 49, pp.1178~1185 (2011)
75. McGee-Lawrence ME., "Sclerostin deficient mice rapidly heal bone defects by activating beta-catenin and increasing intramembranous ossification", Biochem Biophys Res Commun., 441, pp.886~890 (2013)
76. Caetano-Lopes J., "Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing", PLoS One., 6, pp.e16947~ (2011)
77. Gamie Z., "Sclerostin monoclonal antibodies on bone metabolism and fracture healing", Expert Opin Investig Drugs., 21, pp.1523~1534 (2012)
78. Virk MS., "Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model", J Bone Joint Surg Am., 95, pp.694~701 (2013)
79. Nakajima A., "Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34)", J Bone Miner Res., 17, pp.2038~2047 (2002)
80. Ellegaard M., "The effect of PTH (1-34) on fracture healing during different loading conditions", J Bone Miner Res., 28, pp.2145~2155 (2013)
81. Meinel L., "Localized insulin-like growth factor I delivery to enhance new bone formation", Bone., 33, pp.660~672 (2003)
82. Schmidmaier G., "Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-beta1", Bone., 31, pp.165~172 (2002)
83. Augat P., "Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone", Osteoporos Int., 16(Suppl 2), pp.S36~43 (2005)
84. Ulstrup AK., "Biomechanical concepts of fracture healing in weight-bearing long bones", Acta Orthop Belg., 74, pp.291~302 (2008)
85. Sheng MH., "Conditional knockout of IGF-I in osteocytes surprisingly accelerates fracture repair", ASBMR 2011 Annual Meeting (2011), American Society for Bone and Mineral Research
86. Rundle CH., "Accelerated bony union during fracture healing in osteocyte-specific IGF-1 knockout mice", ORS 2013 Annual Meeting (2011), Orthopaedic Research Society
87. Sheng MH., "Evidence that osteocytes elaborate endocrine regulation of internal organs size: data from the osteocytes IGF-I conditional knockout mice", ASBMR 2011 Annual Meeting (2011), American Society for Bone and Mineral Research
88. Schafer AL., "Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study)", J Clin Endocrinol Metab., 96, pp.E1982~1989 (2011)
89. Barolo S., "Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling", Genes Dev., 16, pp.1167~1181 (2002)
90. Pan D., "Hippo signaling in organ size control", Genes Dev., 21, pp.886~897 (2007)
91. Camargo FD., "YAP1 increases organ size and expands undifferentiated progenitor cells", Curr Biol., 17, pp.2054~2060 (2007)
92. Dong J., "Elucidation of a universal size-control mechanism in Drosophila and mammals", Cell., 130, pp.1120~1133 (2007)
93. Song H., "Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression", Proc Natl Acad Sci U S A., 107, pp.1431~1436 (2010)
94. Zhao B., "The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal", Nat Cell Biol., 13, pp.877~883 (2011)
95. Schmidmaier G., "Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1", Acta Orthop Scand., 74, pp.604~610 (2003)

관련 논문AI추천